Literature DB >> 9125441

Nerve growth factor induces Fos-like immunoreactivity within identified cholinergic neurons in the adult rat basal forebrain.

R B Gibbs1, C Martynowski.   

Abstract

Immunocytochemical techniques were used to examine and compare the effects of intracerebroventricular administration of nerve growth factor (NGF) on Fos expression within identified cholinergic and non-cholinergic neurons located in different regions of the adult rat basal forebrain. Animals were killed 1, 3, 6, and 12 h after receiving NGF (0.5 or 5.0 microg) or vehicle into the left lateral ventricle and sections through the medial septum, diagonal band of Broca, nucleus basalis magnocellularis, and striatum were processed for the combined immunocytochemical detection of Fos and choline acetyltransferase (a marker for cholinergic neurons), or Fos and parvalbumin (a marker for gamma aminobutyric acid (GABA)-containing neurons). NGF produced a significant increase in the percentage of cholinergic neurons containing Fos-like immunoreactivity within all four regions examined. The largest increases were detected in the medial septum (47.8%) and the horizontal limb of the diagonal band of Broca (67.7%). In these areas, NGF-mediated induction of Fos-like immunoreactivity was detected as early as 3 h, peaked at 6 h, and was reduced by 12 h, postinfusion. Small but significant increases in the percentage of cholinergic neurons containing Fos-like immunoreactivity were also detected in the striatum (4.2%) and in the nucleus basalis magnocellularis (19.2%) 3-12 h following administration of the higher dose of NGF. No evidence for an NGF-mediated induction of Fos within parvalbumin-containing neurons was detected in any of the four regions at any of the time-points examined; however, evidence for an NGF-mediated induction of Fos within epithelial cells lining the lateral ventricle was observed. These data demonstrate that NGF induces Fos expression within cholinergic, and not parvalbumin-containing (GABAergic), neurons in the basal forebrain, and furthermore that intracerebroventricular administration of NGF influences the different subgroups of basal forebrain cholinergic neurons to different degrees.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125441     DOI: 10.1016/s0006-8993(97)00006-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Nerve growth factor in the hippocamposeptal system: evidence for activity-dependent anterograde delivery and modulation of synaptic activity.

Authors:  Lan Guo; Mason L Yeh; Verginia C Cuzon Carlson; Erin M Johnson-Venkatesh; Hermes H Yeh
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

2.  Molecular mechanisms regulating NGF-mediated enhancement of cholinergic neuronal phenotype: c-fos trans-activation of the choline acetyltransferase gene.

Authors:  J L Pongrac; R J Rylett
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

3.  Synaptogenesis and myopathy under acetylcholinesterase overexpression.

Authors:  E Lev-Lehman; T Evron; R S Broide; E Meshorer; I Ariel; S Seidman; H Soreq
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

4.  c-Fos protein expression is increased in cholinergic neurons of the rodent basal forebrain during spontaneous and induced wakefulness.

Authors:  J T McKenna; J W Cordeira; B A Jeffrey; C P Ward; S Winston; R W McCarley; R E Strecker
Journal:  Brain Res Bull       Date:  2009-08-28       Impact factor: 4.077

5.  The Medial Septum Is Insulin Resistant in the AD Presymptomatic Phase: Rescue by Nerve Growth Factor-Driven IRS1 Activation.

Authors:  Valentina Sposato; Nadia Canu; Elena Fico; Salvatore Fusco; Giulia Bolasco; Maria Teresa Ciotti; Matteo Spinelli; Delio Mercanti; Claudio Grassi; Viviana Triaca; Pietro Calissano
Journal:  Mol Neurobiol       Date:  2018-05-07       Impact factor: 5.590

6.  hNGF Peptides Elicit the NGF-TrkA Signalling Pathway in Cholinergic Neurons and Retain Full Neurotrophic Activity in the DRG Assay.

Authors:  Viviana Triaca; Elena Fico; Valentina Sposato; Silvia Caioli; Maria Teresa Ciotti; Cristina Zona; Delio Mercanti; Diego La Mendola; Cristina Satriano; Enrico Rizzarelli; Paola Tirassa; Pietro Calissano
Journal:  Biomolecules       Date:  2020-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.